William Aliski, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 3,750 shares at $76.66 ($287K) on 2018-08-08, disclosed to the SEC on 2018-08-08.
Open-market sale of $287k RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2020-06-03 | $1.5M | — | Filing → |
| RARE | SELL | 2020-05-20 | $560K | — | Filing → |
| AGTC | BUY | 2018-12-18 | $19K | — | Filing → |